XML 57 R61.htm IDEA: XBRL DOCUMENT v2.4.1.9
Joint Ventures and Other Equity Method Affiliates - Equity Income from Affiliates (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Equity Income from Affiliates [Line Items]      
Equity income from affiliates $ 257us-gaap_IncomeLossFromEquityMethodInvestments $ 404us-gaap_IncomeLossFromEquityMethodInvestments $ 642us-gaap_IncomeLossFromEquityMethodInvestments
Other [Member]      
Equity Income from Affiliates [Line Items]      
Equity income from affiliates 65us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= us-gaap_OtherAffiliatesMember
[1] 52us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= us-gaap_OtherAffiliatesMember
[1] 21us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= us-gaap_OtherAffiliatesMember
[1]
AstraZeneca LP [Member]      
Equity Income from Affiliates [Line Items]      
Equity income from affiliates $ 192us-gaap_IncomeLossFromEquityMethodInvestments
/ dei_LegalEntityAxis
= us-gaap_PartnershipInterestMember
[2] $ 352us-gaap_IncomeLossFromEquityMethodInvestments
/ dei_LegalEntityAxis
= us-gaap_PartnershipInterestMember
[2] $ 621us-gaap_IncomeLossFromEquityMethodInvestments
/ dei_LegalEntityAxis
= us-gaap_PartnershipInterestMember
[2]
[1] Includes results from Sanofi Pasteur MSD.
[2] As noted below, as of July 1, 2014, the Company no longer records equity income from AZLP.